[Acupoint application therapy for diarrhea-predominant irritable bowel syndrome with spleen deficiency and dampness retention: a randomized controlled trial].
摘要
OBJECTIVES: To observe the clinical efficacy of acupoint application in the treatment of diarrhea type irritable bowel syndrome (IBS-D) with spleen deficiency and dampness retention. METHODS: 88 patients with spleen deficiency and dampness retention type IBS-D were randomly divided into a control group (44 cases, 1 case dropped out, 1 exclusion) and an experimental group (44 cases, 2 cases dropped out). The control group was given Bifidobacterium triple active bacteria capsules (Bifico) orally, 0.48 g each time, twice a day. Patients in the experimental group applied joint acupoint plaster to Shenque (CV8) in addition to the control group for 12 h each time, once a day. Both groups underwent treatment for 7 d per course, totaling 4 courses. The traditional Chinese medicine syndrome score, IBS severity scale (IBS-SSS) score, and IBS stool characteristics questionnaire (IBS-DSQ) score of the 2 groups were recorded before and after 4 weeks of treatment, and the clinical efficacy of the 2 groups were observed. RESULTS: <0.05). CONCLUSIONS: Acupoint application at CV8 can effectively improve diarrhea, abdominal pain, abdominal distension, and stool characteristics in patients with spleen deficiency and dampness retention type IBS-D, and improve their quality of life. The efficacy is definite, safe, and reliable, and it is worthy of further clinical promotion and application.